Ireland
--:--IST
Starting soon Not applicable

Effect of Storytelling on Questionnaire Completion and Quality of Collected Data in an E-Cohort

NCT07475338 · tracked via the Priya Life Science France tracker
Sponsor
SKEZI
Phase
Not applicable
Started
2026-03
Last updated
2026-03-16

Condition(s) studied

General Population (no Specific Condition or Disease)

Investigational drug(s) / intervention(s)

Storytelling questionnaire

Storytelling questionnaire: In the context of the SKETHIS e-cohort, participants receive an email inviting them to complete a new online questionnaire regarding their physical activity. Participants are unaware that the experiment is being conducted or that the questionnaire uses storytelling.

Study summary

This study is a randomized controlled trial, nested in the SKETHIS e-cohort, aiming to evaluate whether adding a modest, narrative-driven, strorytelling introduction to a Patient-Reported Outcome questionnaire increases completion without compromising data quality.

This trial is led by SKEZI, a DeepTech start-up which markets a data collection solution and carries out the InnoPRO program, aimed at generating new knowledge in the field of e-cohorts.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Being a current SKETHIS participant (eligibiliy criteria: being 18 or older, living in France, reading and understanding French, having a digital device with internet access and a valid e-mail address) * Having completed the main SKETHIS questionnaire and the socio-demographic information questionnaire * Providing consent to participate to the study Exclusion Criteria: \- Answering "I am unable to walk out" to the EQ-5D mobility item part of the main SKETHIS questionnaire (cannot complete Global Physical Activity Questionnaire)

Primary outcome measure(s)

  • Completion rate — 30 days after sending the questionnaire
    Proportion of participants who complete the Patient-Reported Outcome questionnaire within 30 days after the questionnaire is first sent, calculated as number of participants who fully completed the questionnaire divided by total number of participants included in the study (or arm)

Trial sites (1)

FacilityCityRegionStatus
SKEZI Paris France
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07475338 on ClinicalTrials.gov ↗ ← All trials in France